Novartis (NVS) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 02/04/26
Novartis delivered high single-digit sales growth, achieved 40% core margin and further advanced the pipeline in 2025GlobeNewsWire • 02/04/26
Exploring Analyst Estimates for Novartis (NVS) Q4 Earnings, Beyond Revenue and EPSZacks Investment Research • 01/30/26
Novartis' Ianalumab Wins Breakthrough Therapy Tag for Sjogren's DiseaseZacks Investment Research • 01/19/26
Winners & Losers: The ETF Playbook to Glide Trump's Great Healthcare PlanZacks Investment Research • 01/19/26
Zonsen PepLib Biotech and Novartis Sign Worldwide License Agreement regarding Radioligand Therapy AssetBusiness Wire • 01/13/26
Novartis AG (NVS) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/12/26
Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investmentGlobeNewsWire • 01/09/26
Nine pharmaceutical companies including Bristol-Myers Squibb, GSK and Merck agreed to lower the prices that certain federal government programs and patients payWSJ • 12/19/25